67 related articles for article (PubMed ID: 26219281)
1. An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with familial hypercholesterolemia.
Broekhuizen K; van Wier MF; Koppes LL; Brug J; van Mechelen W; Bosmans JE; van Poppel MN
BMC Res Notes; 2015 Jul; 8():317. PubMed ID: 26219281
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.
Villa G; Lothgren M; Kutikova L; Lindgren P; Gandra SR; Fonarow GC; Sorio F; Masana L; Bayes-Genis A; Hout BV
Clin Ther; 2017 Apr; 39(4):771-786.e3. PubMed ID: 28366593
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
Chen CX; Hay JW
Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
[TBL] [Abstract][Full Text] [Related]
4. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a distance lifestyle counselling programme among overweight employees from a company perspective, ALIFE@Work: a randomized controlled trial.
Gussenhoven AH; van Wier MF; Bosmans JE; Dekkers JC; van Mechelen W
Work; 2013 Jan; 46(3):337-46. PubMed ID: 23324710
[TBL] [Abstract][Full Text] [Related]
6. No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.
Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
BMC Res Notes; 2012 Jul; 5():181. PubMed ID: 22490761
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis.
de Kinderen RJ; Lambrechts DA; Wijnen BF; Postulart D; Aldenkamp AP; Majoie MH; Evers SM
Epilepsia; 2016 Jan; 57(1):41-50. PubMed ID: 26617284
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of involving nurse specialists for adult patients with urinary incontinence in primary care compared to care-as-usual: an economic evaluation alongside a pragmatic randomized controlled trial.
Albers-Heitner CP; Joore MA; Winkens RA; Lagro-Janssen AL; Severens JL; Berghmans LC
Neurourol Urodyn; 2012 Apr; 31(4):526-34. PubMed ID: 22275126
[TBL] [Abstract][Full Text] [Related]
10. Cost of lipid lowering in patients with coronary artery disease by case method learning.
Kiessling A; Zethraeus N; Henriksson P
Int J Technol Assess Health Care; 2005; 21(2):180-6. PubMed ID: 15921057
[TBL] [Abstract][Full Text] [Related]
11. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes.
Irvine L; Barton GR; Gasper AV; Murray N; Clark A; Scarpello T; Sampson M
Int J Technol Assess Health Care; 2011 Oct; 27(4):275-82. PubMed ID: 22004767
[TBL] [Abstract][Full Text] [Related]
14. Is the process of delivery of an individually tailored lifestyle intervention associated with improvements in LDL cholesterol and multiple lifestyle behaviours in people with familial hypercholesterolemia?
Broekhuizen K; Jelsma JG; van Poppel MN; Koppes LL; Brug J; van Mechelen W
BMC Public Health; 2012 May; 12():348. PubMed ID: 22583789
[TBL] [Abstract][Full Text] [Related]
15. A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.
Broekhuizen K; van Poppel MN; Koppes LL; Brug J; van Mechelen W
BMC Public Health; 2010 Feb; 10():69. PubMed ID: 20156339
[TBL] [Abstract][Full Text] [Related]
16. Oral nutritional support in malnourished elderly decreases functional limitations with no extra costs.
Neelemaat F; Bosmans JE; Thijs A; Seidell JC; van Bokhorst-de van der Schueren MA
Clin Nutr; 2012 Apr; 31(2):183-90. PubMed ID: 22071290
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness for acupuncture in seasonal allergic rhinitis: economic results of the ACUSAR trial.
Reinhold T; Roll S; Willich SN; Ortiz M; Witt CM; Brinkhaus B
Ann Allergy Asthma Immunol; 2013 Jul; 111(1):56-63. PubMed ID: 23806461
[TBL] [Abstract][Full Text] [Related]
19. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
20. Cost-utility analysis of osteopathy in primary care: results from a pragmatic randomized controlled trial.
Williams NH; Edwards RT; Linck P; Muntz R; Hibbs R; Wilkinson C; Russell I; Russell D; Hounsome B
Fam Pract; 2004 Dec; 21(6):643-50. PubMed ID: 15531626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
